Market Overview

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC

Related SNY
ECB Decision Boosts ETFs
The 4 Companies Teaming Up For A New Tool To Fight Cancer
Allergan Reportedly Seeks Alternate Suitor (Fox Business)
Related JNJ
3 Companies Investing In Stem Cell Research
Johnson & Johnson Metal Hip Might Lead To Poisoning, Facing 6,000+ Suits
U.S., U.K. ISIS Response Differ Widely (Fox Business)

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A

 

Related Articles (JNJ + SNY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters